{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T16:01:21Z","timestamp":1718640081562},"reference-count":24,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.3892\/mmr.2017.7835","type":"journal-article","created":{"date-parts":[[2017,10,19]],"date-time":"2017-10-19T11:31:33Z","timestamp":1508412693000},"page":"9409-9414","source":"Crossref","is-referenced-by-count":8,"title":["Semi-random mutagenesis profile of BCR-ABL during imatinib resistance acquirement in K562 cells"],"prefix":"10.3892","volume":"16","author":[{"given":"Yan","family":"Dong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaotong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingxin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengying","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingmin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guodong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2017,10,19]]},"reference":[{"key":"key20180108005842_b1-mmr-16-06-9409","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1002\/cncr.26679","article-title":"Estimations of the increasing prevalence and plateau prevalence of chronic myeloid leukemia in the era of tyrosine kinase inhibitors therapy","volume":"118","author":"Huang","year":"2012","journal-title":"Cancer"},{"key":"key20180108005842_b2-mmr-16-06-9409","doi-asserted-by":"crossref","first-page":"252ra121","DOI":"10.1126\/scitranslmed.3009073","article-title":"A therapeutically targetable mechanism of BCR-ABL-independent imatinib resistance in chronic myeloid leukemia","volume":"6","author":"Ma","year":"2014","journal-title":"Sci Transl Med"},{"key":"key20180108005842_b3-mmr-16-06-9409","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1056\/NEJMoa030513","article-title":"Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia","volume":"349","author":"Hughes","year":"2003","journal-title":"N Engl J Med"},{"key":"key20180108005842_b4-mmr-16-06-9409","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.leukres.2016.08.006","article-title":"Resistance to imatinib in patients with chronic myelogenous leukemia and the splice variant BCR-ABL1 (35INS)","volume":"49","author":"Berman","year":"2016","journal-title":"Leuk Res"},{"key":"key20180108005842_b5-mmr-16-06-9409","first-page":"e3961","article-title":"New developments in chronic myeloid leukemia: Implications for therapy","volume":"9","author":"Tabarestani","year":"2016","journal-title":"Iran J Cancer Prev"},{"key":"key20180108005842_b6-mmr-16-06-9409","doi-asserted-by":"crossref","first-page":"35533","DOI":"10.1038\/srep35533","article-title":"Aurora A kinase inhibitor AKI603 induces cellular senescence in chronic myeloid leukemia cells harboring T315I mutation","volume":"6","author":"Wang","year":"2016","journal-title":"Sci Rep"},{"key":"key20180108005842_b7-mmr-16-06-9409","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/leu.2010.238","article-title":"Seeking the causes and solutions to imatinib-resistance in chronic myeloid leukemia","volume":"25","author":"Bixby","year":"2011","journal-title":"Leukemia"},{"key":"key20180108005842_b8-mmr-16-06-9409","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.canlet.2016.09.025","article-title":"PBA2, a novel inhibitor of imatinib-resistant BCR-ABL T315I mutation in chronic myeloid leukemia","volume":"383","author":"Gupta","year":"2016","journal-title":"Cancer Lett"},{"key":"key20180108005842_b9-mmr-16-06-9409","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/bies.201100010","article-title":"Does constructive neutral evolution play an important role in the origin of cellular complexity? Making sense of the origins and uses of biological complexity","volume":"33","author":"Speijer","year":"2011","journal-title":"Bioessays"},{"key":"key20180108005842_b10-mmr-16-06-9409","unstructured":"SongYShiYCarlandTMLianSSasakiTSchorkNJHeadSRKishiSSchimmelPp53-Dependent DNA damage response sensitive to editing-defective tRNA synthetase in zebrafishProc Natl Acad Sci USA11384608465201610.1073\/pnas.1608139113274027634968768"},{"key":"key20180108005842_b11-mmr-16-06-9409","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.crvi.2016.04.004","article-title":"Non-functional genes repaired at the RNA level","volume":"339","author":"Burger","year":"2016","journal-title":"C R Biol"},{"key":"key20180108005842_b12-mmr-16-06-9409","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1126\/science.959840","article-title":"The clonal evolution of tumor cell populations","volume":"194","author":"Nowell","year":"1976","journal-title":"Science"},{"key":"key20180108005842_b13-mmr-16-06-9409","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1113205","article-title":"Intratumor heterogeneity and branched evolution revealed by multiregion sequencing","volume":"366","author":"Gerlinger","year":"2012","journal-title":"N Engl J Med"},{"key":"key20180108005842_b14-mmr-16-06-9409","unstructured":"SchwerBWeiPCChangANKaoJDuZMeyersRMAltFWTranscription-associated processes cause DNA double-strand breaks and translocations in neural stem\/progenitor cellsProc Natl Acad Sci USA11322582263201610.1073\/pnas.1525564113268731064776469"},{"key":"key20180108005842_b15-mmr-16-06-9409","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.tcb.2015.07.009","article-title":"Repair pathway choices and consequences at the double-strand break","volume":"26","author":"Ceccaldi","year":"2016","journal-title":"Trends Cell Biol"},{"key":"key20180108005842_b16-mmr-16-06-9409","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1038\/nn.3539","article-title":"Deciphering the functions and regulation of brain-enriched A-to-I RNA editing","volume":"16","author":"Li","year":"2013","journal-title":"Nat Neurosci"},{"key":"key20180108005842_b17-mmr-16-06-9409","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/jmcb\/mjr005","article-title":"The agents of natural genome editing","volume":"3","author":"Witzany","year":"2011","journal-title":"J Mol Cell Biol"},{"key":"key20180108005842_b18-mmr-16-06-9409","doi-asserted-by":"crossref","first-page":"5093","DOI":"10.1093\/nar\/gkp532","article-title":"A trans-splicing group I intron and tRNA-hyperediting in the mitochondrial genome of the lycophyte Isoetes engelmannii","volume":"37","author":"Grewe","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"key20180108005842_b19-mmr-16-06-9409","doi-asserted-by":"crossref","first-page":"7112","DOI":"10.1093\/nar\/gkq591","article-title":"Intron RNA editing is essential for splicing in plant mitochondria","volume":"38","author":"Castandet","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"key20180108005842_b20-mmr-16-06-9409","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1074\/mcp.M117.067439","article-title":"Quantitative tyrosine phosphoproteomics of Epidermal Growth Factor Receptor (EGFR) tyrosine kinase inhibitor-treated lung adenocarcinoma cells reveals potential novel biomarkers of therapeutic response","volume":"16","author":"Zhang","year":"2017","journal-title":"Mol Cell Proteomics"},{"key":"key20180108005842_b21-mmr-16-06-9409","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.cell.2017.01.018","article-title":"Clonal heterogeneity and tumor evolution: Past, present, and the future","volume":"168","author":"McGranahan","year":"2017","journal-title":"Cell"},{"key":"key20180108005842_b22-mmr-16-06-9409","doi-asserted-by":"crossref","first-page":"37331","DOI":"10.18632\/oncotarget.7949","article-title":"The clinical value of aberrant epigenetic changes of DNA damage repair genes in human cancer","volume":"7","author":"Gao","year":"2016","journal-title":"Oncotarget"},{"key":"key20180108005842_b23-mmr-16-06-9409","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.1088759","article-title":"Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2","volume":"302","author":"King","year":"2003","journal-title":"Science"},{"key":"key20180108005842_b24-mmr-16-06-9409","first-page":"1135","article-title":"The mRNA level of MLH1 in peripheral blood is a biomarker for the diagnosis of hereditary nonpolyposis colorectal cancer","volume":"6","author":"Yu","year":"2016","journal-title":"Am J Cancer Res"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"language":"en","deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T02:01:05Z","timestamp":1515376865000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mmr.2017.7835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,19]]},"references-count":24,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,10,19]]},"published-print":{"date-parts":[[2017,12]]}},"alternative-id":["10.3892\/mmr.2017.7835"],"URL":"https:\/\/doi.org\/10.3892\/mmr.2017.7835","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,19]]}}}